IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 83 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $364,000 | +12.0% | 40,815 | -83.4% | 0.04% | +2.9% |
| Q2 2018 | $325,000 | -28.4% | 246,527 | 0.0% | 0.03% | -33.3% |
| Q1 2018 | $454,000 | -12.7% | 246,527 | 0.0% | 0.05% | -8.9% |
| Q4 2017 | $520,000 | -5.5% | 246,527 | 0.0% | 0.06% | -9.7% |
| Q3 2017 | $550,000 | +29.7% | 246,527 | 0.0% | 0.06% | +24.0% |
| Q2 2017 | $424,000 | -30.4% | 246,527 | 0.0% | 0.05% | -33.3% |
| Q1 2017 | $609,000 | +64.6% | 246,527 | 0.0% | 0.08% | +50.0% |
| Q4 2016 | $370,000 | -41.4% | 246,527 | 0.0% | 0.05% | -51.9% |
| Q3 2016 | $631,000 | +67.4% | 246,527 | 0.0% | 0.10% | +60.0% |
| Q2 2016 | $377,000 | -22.7% | 246,527 | 0.0% | 0.06% | -25.3% |
| Q1 2016 | $488,000 | -21.0% | 246,527 | +23.3% | 0.09% | -20.9% |
| Q4 2015 | $618,000 | -7.8% | 200,000 | 0.0% | 0.11% | -19.7% |
| Q3 2015 | $670,000 | -9.7% | 200,000 | 0.0% | 0.14% | -4.9% |
| Q2 2015 | $742,000 | 0.0% | 200,000 | 0.0% | 0.14% | -4.6% |
| Q1 2015 | $742,000 | -15.9% | 200,000 | 0.0% | 0.15% | -18.8% |
| Q4 2014 | $882,000 | – | 200,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|